secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kalaris Therapeutics, Inc. (KLRS)
CIK:        0001754068
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001193125-24-159226
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AlloVir terminates Waltham sublease, agrees to pay $5.7M termination fee
------------------------------------------------------------------------

- Sublease terminated effective June 30, 2024; originally set to expire July 31, 2028.
- AlloVir will pay $5.7 million termination fee to AMAG Pharmaceuticals.
- AlloVir released from future rent obligations; no restoration beyond broom-clean required.
- Security deposit of $297,717 to be returned per sublease terms.
- Landlord BP Bay Colony LLC consented to termination on June 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1754068/000119312524159226/0001193125-24-159226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1754068/000119312524159226/d830314d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-159226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer